These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447 [TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Roy B; Taneja R; Chambon P Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423 [TBL] [Abstract][Full Text] [Related]
5. An RXR-selective analog attenuates the RAR alpha-selective analog-induced differentiation and non-G1-restricted growth arrest of NB4 cells. Brooks SC; Sturgill R; Choi J; Yen A Exp Cell Res; 1997 Aug; 234(2):259-69. PubMed ID: 9260893 [TBL] [Abstract][Full Text] [Related]
6. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Duprez E; Lillehaug JR; Gaub MP; Lanotte M Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786 [TBL] [Abstract][Full Text] [Related]
7. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071 [TBL] [Abstract][Full Text] [Related]
10. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679 [TBL] [Abstract][Full Text] [Related]
11. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
12. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [TBL] [Abstract][Full Text] [Related]
13. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells. Makishima M; Shudo K; Honma Y Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315 [TBL] [Abstract][Full Text] [Related]
14. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895 [TBL] [Abstract][Full Text] [Related]
17. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha. Duprez E; Lillehaug JR; Naoe T; Lanotte M Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787 [TBL] [Abstract][Full Text] [Related]
18. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Jansen JH; Mahfoudi A; Rambaud S; Lavau C; Wahli W; Dejean A Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7401-5. PubMed ID: 7638205 [TBL] [Abstract][Full Text] [Related]
19. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. Howell SR; Shirley MA; Ulm EH Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386 [TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Johnson BS; Chandraratna RA; Heyman RA; Allegretto EA; Mueller L; Collins SJ Mol Cell Biol; 1999 May; 19(5):3372-82. PubMed ID: 10207061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]